Accuray (ARAY) Long-Term Deferred Tax (2011 - 2026)

Accuray (ARAY) posted quarterly Long-Term Deferred Tax of $694000.0 for Q1 2026, down 1.84% quarter-over-quarter from $707000.0 in Q4 2025.

Accuray (ARAY) Long-Term Deferred Tax (2011 - 2026) Analysis & Trends

Accuray's Long-Term Deferred Tax history runs 11 years deep, the most recent figure standing at $694000.0 for Q1 2026.

In Q1 2026, Long-Term Deferred Tax changed N/A year-over-year to $694000.0; the TTM figure through Mar 2026 stood at $694000.0 (changed N/A YoY), while the FY2025 annual figure was $756000.0, up 14.72% from the prior year.
Long-Term Deferred Tax for Q1 2026 stood at $694000.0, down from $707000.0 in the prior quarter.
The five-year high for Long-Term Deferred Tax was $756000.0 in Q2 2025, with the low at $659000.0 in Q2 2024.
The 3-year median for Long-Term Deferred Tax is $707000.0 (2025), against an average of $710800.0.
Peak annual rise in Long-Term Deferred Tax reached 14.72% in 2025, while the deepest fall reached 14.72% in 2025.
Accuray's Long-Term Deferred Tax stood at $659000.0 in 2024, then increased by 7.28% to $707000.0 in 2025, then declined by 1.84% to $694000.0 in 2026.
Business Quant data shows ARAY's Long-Term Deferred Tax at $694000.0 in Q1 2026, $707000.0 in Q4 2025, and $738000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.24 Bn	193.64 Bn	7.27 Bn
2	Stryker	128.63 Bn	125.15 Bn	4.50 Bn
3	Medtronic	119.19 Bn	109.97 Bn	6.41 Bn
4	Boston Scientific	73.51 Bn	72.97 Bn	3.85 Bn
5	Edwards Lifesciences	52.11 Bn	47.85 Bn	1.35 Bn
6	Dexcom	34.64 Bn	32.70 Bn	830.00 Mn
7	GE HealthCare Technologies	34.01 Bn	31.90 Bn	2.18 Bn
8	Koninklijke Philips	26.40 Bn	23.08 Bn	4.55 Bn
9	Steris	23.14 Bn	22.65 Bn	684.20 Mn
10	Accuray	37.80 Mn	-1.90 Mn	25.29 Mn

Download Data